**Gain the Decision Advantage**

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

# Resource Library

### **Featured Resources**

### [Safety  Case Study  **Modernizing Safety Operations with AI: How Bristol Myers Squibb Achieved 25% Efficiency Gains in PV Case Intake and Processing**](/content/resources/modernizing-safety-operations-with-ai-how-bristol-myers-squibb-achieved-25-efficiency-gains-in-pv-case-intake-and-processing/index.html)

[Learn More](/content/resources-center/.../index.html)

### [Safety  Webinar  **The Rise of Intelligence Agents**](/content/resources/the-rise-of-intelligence-agents/index.html)

Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal ...

[Learn More](/content/resources/the-rise-of-intelligence-agents/index.html)

### [Safety  Webinar  **Introducing Agentic AI for Signal Management**](/content/resources/introducing-agentic-ai-for-signal-management/index.html)

Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal ...

[Learn More](/content/resources/introducing-agentic-ai-for-signal-management/index.html)

### [Safety  Webinar  **Driving Cross-Domain R&D Insights with Meaning-Aware AI**](/content/resources/driving-cross-domain-rd-insights-with-meaning-aware-ai/index.html)

In this webinar, discover how a unified decision intelligence layer across R&D can connect data, understand context, and harness ...

[Learn More](/content/resources/driving-cross-domain-rd-insights-with-meaning-aware-ai/index.html)

### [Safety  Case Study  **Accelerating End-to-End Safety Assessment Across Fragmented Data with Signals Agents**](/content/resources/accelerating-end-to-end-safety-assessment-across-fragmented-data-with-signals-agents/index.html)

[Learn More](/content/resources/accelerating-end-to-end-safety-assessment-across-fragmented-data-with-signals-agents/index.html)

### [Regulatory  Case Study  **Transforming Regulatory Operations with AI: Why Frost & Sullivan Recognized ArisGlobal as a Visionary Leader**](/content/resources/why-frost-sullivan-recognized-arisglobal-as-a-visionary-leader/index.html)

[Learn More](/content/resources/why-frost-sullivan-recognized-arisglobal-as-a-visionary-leader/index.html)

### [Safety  Checklist  **Harness AI in Safety – Without the Risk: A Practical Checklist**](/content/resources/harness-ai-in-safety-without-the-risk-a-practical-checklist/index.html)

In our practical checklist, we walk through the most important criteria to consider when evaluating AI solutions and technology ...

[Learn More](/content/resources/harness-ai-in-safety-without-the-risk-a-practical-checklist/index.html)

### [Safety  Guide  **The AI Integration Roadmap for Pharmacovigilance**](/content/resources/the-ai-integration-roadmap-for-pharmacovigilance/index.html)

In our guide, we outline the key considerations life sciences organizations should address when building and scaling an AI ...

[Learn More](/content/resources/the-ai-integration-roadmap-for-pharmacovigilance/index.html)

### [Safety  Webinar  **Leveraging Conversational AI for Intelligent Adverse Event and Product Complaint Intake**](/content/resources/leveraging-conversational-ai-for-intelligent-adverse-event-and-product-complaint-intake/index.html)

Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal ...

[Learn More](/content/resources/leveraging-conversational-ai-for-intelligent-adverse-event-and-product-complaint-intake/index.html)

### [Regulatory  Checklist  **Building AI Success in Regulatory Affairs: A Practical Checklist**](/content/resources/building-ai-success-in-regulatory-affairs-a-practical-checklist/index.html)

In our practical checklist, we walk through the most important criteria to consider when evaluating AI solutions and technology ...

[Learn More](/content/resources/building-ai-success-in-regulatory-affairs-a-practical-checklist/index.html)

### [Regulatory  Fact Sheet  **Transform Regulatory Affairs with AI Innovation**](/content/resources/transform-ra-with-ai-innovation/index.html)

Learn how our industry-leading LifeSphere Regulatory platform, powered by NavaX™ AI is helping life sciences organizations drive ...

[Learn More](/content/resources/transform-ra-with-ai-innovation/index.html)

[Learn More](/content/resources-center/.../index.html)

### [Safety  Webinar  **The Rise of Intelligence Agents**](/content/resources/the-rise-of-intelligence-agents/index.html)

Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal ...

[Learn More](/content/resources/the-rise-of-intelligence-agents/index.html)

### [Safety  Webinar  **Introducing Agentic AI for Signal Management**](/content/resources/introducing-agentic-ai-for-signal-management/index.html)

Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal ...

[Learn More](/content/resources/introducing-agentic-ai-for-signal-management/index.html)

### [Safety  Checklist  **AI-Powered Regulatory Intelligence Checklist**](/content/resources/ai-powered-regulatory-intelligence-checklist/index.html)

In our checklist, we outline the most important criteria that leading organizations are keeping in mind when evaluating Agentic ...

[Learn More](/content/resources/ai-powered-regulatory-intelligence-checklist/index.html)

the latest automation  
from LifeSphere

## Learn more about our collaborative partnership with customers.

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
